The Efficacy of Melissa Officinalis and Nepeta Menthoides Combination on Insomnia

Phase 3

• Conditions: Condition 1: Insomnia. Condition 2: Generalized anxiety disorder. Condition 3: Depression. Condition 4: Insomnia.; Non organic sleep disorders; Generalized anxiety disorder; Depressive episode; Nonorganic sleep disorder, unspecified

• Registration Number: IRCT2015040621592N2
• Lead Sponsor: Shiraz University of Medical ScienceS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Inclusion Criteria: Over 18 year old patients with the diagnosis of insomnia without using allopathic sleep aid medication; Patients with the oral or written informed consent; ISI Score>7
Exclusion critria: Patients with uncontrolled and severe organic or psychiatric diseases and pain disorders which cause insomnia directly or by their treatment ;pregnancy and lactation; alchohol or substance abuse; thyriod disase; any other medication use or their withdrawal which affects sleep; other sleep disorders; history of sever drug reaction to Melissa Off or Nepeta Menthoides

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insomnia. Timepoint: Baseline,second and 4th week. Method of measurement: ,SLEEP LOG.;Depression. Timepoint: Baseline and second and 4th week. Method of measurement: Beck depression inventory.;Generalized anxiety disorder. Timepoint: Baseline and second ,4th week. Method of measurement: Beck anxiety inventory.

Secondary Outcome Measures

Name	Time	Method
Side effects like unusual drug reaction, gi discomfort. Timepoint: During the clinical trial specially on the second ,4th week. Method of measurement: By asking the patient.